Who Paid My Doc
Fluzone High-Dose
Biological Vaccines
NDC 49281-391-65
General payments
$775,201
Research payments
$931,544
Through program year 2025, $775,201 in general payments and $931,544 in research payments were reported against Fluzone High-Dose (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $56,251 | 2,502 |
| 2024 | General | $21,944 | 1,099 |
| 2023 | General | $148,093 | 5,939 |
| 2023 | Research | $4,200 | 1 |
| 2022 | General | $137,922 | 2,441 |
| 2022 | Research | $172,450 | 3 |
| 2021 | General | $94,993 | 2,273 |
| 2021 | Research | $171,175 | 25 |
| 2020 | General | $315,981 | 4,615 |
| 2020 | Research | $583,719 | 14 |
| 2019 | General | $16 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 62 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
18,870 general · 43 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.